Molina Healthcare — Jul 7, 2025 release
Fiscal 2025 second-quarter results · 8-K Item 2.02 · Exhibit 99.1 · 0001437749-25-022210
Showing in the filing
GAAP Net Income
“$1,045 to $1,099”
Period
FY2025
Measure
GAAP-tied
Source
Guidance table
All guidance in this release · 7
Adjusted earnings per share for Q2 FY2025
“approximately $5.50 per share”
Adjusted earnings per share for FY2025
“$21.50 to $22.50 per share”
Adjusted net income per diluted share for FY2025
“$21.50 to $22.50”
Consolidated pre-tax margin for FY2025
“just under 4%”
GAAP Net Income for FY2025
“$1,045 to $1,099”
GAAP Net income per diluted share for FY2025
“$19.32 to $20.32”
Adjusted Net Income for FY2025
“$1,163 to $1,217”
Exhibit 99.1 · the passage around this item
… earlier in the release
RECONCILIATION OF PRELIMINARY UNAUDITED NON-GAAP FINANCIAL MEASURES
2025 GUIDANCE
(in millions, except per diluted share amounts; unaudited)
Amount
Per Diluted Share (4)
GAAP Net income
$1,045 to $1,099
$19.32 to $20.32
Adjustments:
Amortization of intangible assets
~86
~1.59
Acquisition-related expenses
~66
~1.23
Other
~2
~0.03
Subtotal, adjustments
~154
~2.85
Income tax effect (3)
~(36
)
~(0.67
)
Adjustments, net of tax
~118
~2.18
Adjusted net income
$1,163 to $1,217
$21.50 to $22.50
(3)
Income tax effect calculated at the statutory tax rate of approximately 23.7%.
(4)
Computations assume approximately 54.1 million diluted weighted average shares outstanding.
The Company believes that certain non-GAAP (generally accepted accounting principles) financial measures are useful supplemental measures to investors in comparing the Company’s performance to the performance of other public companies in the health care industry. The non-GAAP financial measures are also used internally to enable management to asse
later in the release …
the item shown at left
other guidance in this release
Text is the filed exhibit, verbatim.